Related by context. All words. (Click for frequent words.) 77 lead molecular radiotherapeutic 76 Xcytrin R 76 targeted radiotherapeutic 75 small molecule chemopotentiator 74 compound AEOL # 74 Technosphere Insulin System 74 candidates Azedra 73 acetonide FA 73 orBec R oral beclomethasone 73 candidate deforolimus 73 molecular imaging radiopharmaceutical 72 motexafin gadolinium Injection 72 Provenge sipuleucel T 72 oral prodrug 72 PORxin TM 72 novel oral anticoagulant 72 orBec ® oral beclomethasone 71 candidate Zemiva 71 topically applied SEPA 71 Iluvien ® 71 IMA# 71 therapeutic monoclonal antibody 71 candidates Azedra TM 71 candidate EFAPROXYN TM 71 treat chronic sinusitis 71 BrachySil TM 71 AFREZZA ® 71 candidate XP# 71 candidate ridaforolimus 71 candidate Zemiva TM 71 delivers fluocinolone acetonide FA 71 IMPDH inhibitor 70 Archexin 70 OvaRex R 70 PrevOnco ™ 70 GVAX ® 70 polysaccharide polymer 70 oncolytic virus therapies 70 TOCOSOL Camptothecin 70 NeuroSTAT ® 70 AFREZZA TM 70 liposomal formulation 70 kidney urologic 70 TBC# 70 CINQUIL 70 efaproxiral 70 Initiates Enrollment 70 Iluvien TM 70 Onalta 70 Zemiva TM 70 Civacir 70 candidate Zenvia 70 sapacitabine CYC# 70 TNFerade ™ 69 Evoltra ® 69 Zalypsis 69 MAGE A3 ASCI 69 investigational pharmacologically unique 69 Presents Preclinical Data 69 bucindolol hydrochloride 69 Initiate Clinical Trial 69 Initiates Clinical 69 RANK Ligand inhibitor 69 ALTROPANE R 69 Prodarsan R 69 acyclovir Lauriad R 69 HuMax TAC 69 Personalized Immunotherapy 69 proprietary intranasal insulin 69 candidate brentuximab vedotin 69 successfully commercialize Iluvien 69 Panzem R 69 radiotherapeutic 69 XP# XP# 69 OMNARIS HFA 69 MKC# MKC# PP 69 next generation URAT1 69 PEGylated interferon 69 SinuNase TM 69 mertansine 69 candidate Gencaro TM 69 gastro intestinal inflammation 69 drug tesmilifene 69 aerosolized AAT 69 drug GAP #B# 69 commercialize deforolimus ARIAD 69 Cleviprex TM clevidipine 69 dextofisopam 69 PANVAC VF 69 Initiates Phase II 69 intranasal formulation 68 oral beclomethasone dipropionate 68 recombinant subunit vaccine 68 Crofelemer budesonide foam 68 Aganocide 68 metaglidasen 68 rxRNA 68 personalized cellular immunotherapy 68 novel emulsion formulation 68 OHR/AVR# 68 THR beta agonist 68 targeted antifolate 68 apricitabine ATC 68 BiovaxID TM 68 SPL# Gel vaginal microbicide 68 Surfaxin LS 68 HDL Selective Delipidation 68 HEPLISAV ™ 68 Files IND 68 LAB CGRP 68 thalidomide Thalomid 68 Panzem ® 68 Generx TM 68 KNS # 68 Trastuzumab DM1 68 HDL Mimetic Peptide 68 R sorafenib tablets 68 Initiates Clinical Trial 68 Initiates Phase III 68 Empatic ™ 68 ACAPODENE TM 68 Fodosine 68 IRX 2 68 allogeneic cell 68 Solazed TM 68 CYT# potent vascular disrupting 68 RECOTHROM ® 68 JAK inhibitor 68 M# rationally 68 SPRYCEL ® 68 Receives Approvable Letter 68 drug ISA# 68 2 methoxyestradiol 68 TNFerade TM 68 Achieves Primary Endpoint 68 Peginterferon alfa 2b 68 PORxin TM platforms 68 either acutely decompensated 68 Presents Preclinical 68 endothelin antagonist 67 accumulate preferentially 67 non porcine pancreatic 67 dipropionate 67 including eniluracil ADH 67 Squalamine 67 IMiDs ® 67 MKC# 67 Anturol ® 67 candidate NGX 67 oral talactoferrin 67 doxepin HCl 67 Completes Patient Enrollment 67 Reports Preclinical Data 67 Maribavir 67 Oral NKTR 67 OncoVex 67 ZOLINZA 67 Solzira ™ 67 fusion enhancers 67 Marqibo TM 67 Soliris eculizumab 67 Vitrasert R 67 Nexavar sorafenib tablets 67 VersaFilm 67 candidate HuCNS SC 67 candidate ATHX 67 DNA RNA Medicines 67 product Fentanyl TAIFUN 67 5 lipoxygenase inhibitor 67 AAG geldanamycin analog 67 Alferon N 67 Zemplar Capsules 67 overactive bladder AA# 67 NexACT ® 67 EVIZON TM 67 candidate epratuzumab 67 sodium Injection 67 vapreotide acetate 67 Panzem R NCD 67 ALN PCS 67 Intermezzo ® zolpidem tartrate 67 Perforomist ™ Inhalation Solution 67 candidate REP# 67 P#X# antagonist 67 BrachySil ™ 67 refractory chronic lymphocytic 67 novel L DOS# 67 riboflavin vitamin B2 67 Auxilium transmucosal film 67 synthetic peptide containing 67 lenalidomide Revlimid R 67 reslizumab 67 BEMA Granisetron 67 Annamycin 67 MOVIPREP R 67 Combivir Kivexa 67 IMiDs ® compound 67 oxypurinol 67 Kosan dependence 67 Receives Orphan Drug Designation 67 Opterone R 67 systemic immunosuppressive drugs 67 Aviptadil 67 Genasense ® oblimersen 67 HepaMate 66 levoleucovorin 66 Perflubutane Polymer Microspheres 66 Myocet 66 molecular chaperone regulation 66 Azedra 66 Meets Primary Endpoint 66 Protexia ® 66 HCV protease inhibitors 66 Begins Dosing 66 BrachySil 66 ABL inhibitor 66 PrevOnco 66 LymphoStat B belimumab 66 Cand5 66 selective estrogen receptor modulator 66 candidate AP# 66 Liprotamase 66 investigational humanized monoclonal antibody 66 oxybutynin ATD TM 66 Onconase 66 IL# PE#QQR 66 Pertuzumab 66 DCVax R 66 RECOTHROM R 66 using VIAdel TM 66 Injectable Suspension 66 OncoVEX 66 Rilonacept 66 Phase III Clinical Trial 66 PROVENGE ® 66 SinuNase ™ 66 Factor VIIa 66 Fludara ® 66 SUTENT ® 66 forodesine 66 Locteron ® 66 Proquin XR 66 TOCOSOL 66 allosteric modulator 66 LEUKINE 66 Potelligent Technology 66 inflammatory autoimmune diseases 66 aldehyde dehydrogenase ALDH2 deficiency 66 riociguat 66 oral picoplatin 66 immunotherapeutic agent 66 RhuDex ® 66 Besivance 66 TRACON Pharmaceuticals 66 immunotherapeutic vaccine 66 SynCon 66 candidates bavituximab 66 treats acute lymphoblastic 66 vitreoretinal disorders 66 agent bevasiranib 66 Aganocide ® 66 blood clot dissolver 66 TransVax ™ 66 proprietary PEGylation 66 Anidulafungin 66 inhaled AAT 66 Zenapax 66 Tovaxin TM 66 IMiDs R 66 relapsed leukemia 66 candidate iSONEP TM 66 acadesine 66 RELOVAIR ™ 66 PDX pralatrexate 66 candidate CRLX# 66 Sphingomab TM 66 FOLOTYN ® 66 leading oral taxane 66 brand ciclesonide HFA 66 Selective Electrochemical Tumor Ablation 66 include Alferon N 66 HuMax 66 EVIZON TM squalamine lactate 66 vosaroxin 66 novel therapeutic antibodies 66 MGd 66 Pentad TM 66 cosmetic cosmeceutical products 66 compound ISA# 66 novel VDA molecule 66 Exelixis compounds 66 Zemiva ™ 66 proprietary intravenous formulation 66 HepaGam B 66 biomodulator 66 Dyloject TM 66 humanized therapeutic 66 sorafenib tablets 66 Fibrin Pad 66 lorvotuzumab mertansine 66 EHT AGN 66 delivery polymer matrix 66 faropenem medoxomil 66 recurrent metastatic ovarian cancer 66 HQK 66 product platforms AZX# 66 progressive metastatic prostate 66 Pruvel TM 66 Cardio Vascu Grow 65 mild vasodilator 65 vaginally administered lidocaine 65 patented Bioral 65 hyaluronidase enzyme 65 vinca alkaloid 65 Interferon beta 65 DPX Survivac 65 Currently RegeneRx 65 Drug Candidate 65 Amplimexon 65 PI3K/Akt pathway inhibitor 65 Submits Biologics License Application 65 Solazed 65 MAXY G# 65 doxercalciferol 65 Duromist ™ 65 docetaxel Taxotere ® 65 Receives Orphan Drug 65 Adnectin 65 Cancidas 65 Dendreon investigational 65 Elotuzumab 65 TRO# 65 Bayer HealthCare Onyx Pharmaceuticals 65 evaluating tivozanib 65 vinorelbine tartrate 65 denileukin diftitox 65 investigational monoclonal antibody 65 nanopharmaceutical 65 Somatuline Depot 65 HuLuc# 65 Homspera TM 65 candidate SILENOR TM 65 YONDELIS 65 Proxinium TM 65 MKC# MT 65 AFREZZA ™ 65 Cethrin R 65 Vidaza azacitidine 65 Zorbtive TM 65 QNEXA ® 65 KL4 Surfactant 65 PGL# 65 velafermin 65 Bosutinib 65 Bezielle 65 synthetic retinoid 65 Hemospan 65 Insegia 65 ONCONASE R 65 personalized dendritic 65 Receives Milestone Payment 65 intravenous acetaminophen 65 oral taxane 65 Dabigatran etexilate 65 Veronate 65 LibiGel ® 65 Renal Cell Carcinoma RCC 65 Bazedoxifene 65 highly purified pasteurized 65 CTAP# Capsules 65 Cx# [002] 65 Aurexis 65 Investigational Treatment 65 volociximab 65 Neulasta R 65 selective A2A adenosine receptor 65 diagnostic radiopharmaceutical 65 ThermoDox R 65 compound perifosine 65 transmucosal delivery 65 personalized immunotherapy 65 interferon gamma 1b 65 hypoxia activated prodrug 65 Bellicum 65 ALN TTR# 65 non nucleoside inhibitor 65 refractory gout 65 CEQ# 65 Pafuramidine 65 targets Galectin receptors 65 NanoCrystal Technology 65 Hsp# Inhibitor 65 virus HCV protease inhibitor 65 ATL# [002] 65 FullTerm 65 tolevamer 65 PNP inhibitor 65 ionotropic glutamate receptor antagonists 65 hoFH 65 Pancreate 65 Actimmune ® 65 metastatic carcinoid 65 Orphan Status 65 candidate Zelrix 65 G#DT 65 VitiGam TM 65 Peyronie disease Frozen Shoulder 65 pharmacokinetic PK study 65 Cytarabine 65 dimebon latrepirdine 65 Temsirolimus 65 JOULFERON 65 Cardiotoxicity 65 5 HT3 antagonist 65 lomitapide 65 commercialize ZYFLO CR 65 thrombin component 65 ospemifene 65 pharmacokinetic equivalence 65 OMNARIS Nasal Spray 65 ReN# 65 Immunotherapeutic 65 Tectin TM 65 Onco TCS 65 monoclonal antibody MAb 65 Aceon 65 Valortim TM 65 IONSYS TM 65 MGN# 65 Vascugel 65 INSPIRE Trial Phase III 65 TLR9 agonist 65 commercialize deforolimus 65 demonstrated antitumor activity 65 HGS ETR1 mapatumumab 65 INTEGRILIN R eptifibatide Injection 65 intranasal insulin product 65 Pimavanserin 65 Aplidin 65 Vaxfectin 65 CIMZIA ™ 65 XL# anticancer compounds 65 Campath alemtuzumab 65 Entereg TM 65 Octreolin 65 paclitaxel poliglumex 65 Glufosfamide 65 Neo Urinary Conduit 65 Inhaled nitric oxide 65 wilate ® 65 NASH Huntington 65 Aflibercept 65 PREOS R 65 Safinamide 65 Vascular Wrap TM 65 histone deacetylase inhibitor 65 Fortical R 65 histone deacetylase HDAC inhibitor 65 Pruvel 65 MAXY VII 65 small molecule tyrosine 65 albiglutide 65 Initiates Clinical Trials 65 Dual Opioid TM 65 include Altastaph TM 65 torezolid phosphate 65 orally administered inhibitor 65 autologous cellular immunotherapy 65 Anavex #-# 65 UltiMAb R technology 65 sumatriptan DosePro 65 ENMD # 65 dasatinib Sprycel 65 Submits NDA 65 manufactures minimally invasive 65 LymphoStat B TM 65 Tesmilifene 65 Submits Response 65 Dapagliflozin 65 Veronate R 65 BEMA TM Fentanyl 65 Zysolin TM 65 DNAwithPap TM Test 65 Navelbine ® 65 RNAi Therapeutic 65 Gamunex C 65 rheumatoid arthritis thrombocytopenia 65 apomorphine hydrochloride 65 Combination REOLYSIN R 65 Progenta TM 65 novel DACH platinum 65 Alfacell proprietary ribonuclease 65 Intravenous CP 65 PDE4 inhibitor 65 MYDICAR ® 65 topical anti infective 65 developing TB4 65 treat refractory angina 65 oral anti arrhythmic 65 Aliskiren 64 ATPace TM 64 Vivecon 64 rhIGF-I/rhIGFBP-3 64 StaphVAX R 64 midstage clinical 64 DP VPA 64 compound INCB# 64 Nexavar sorafenib 64 Xanafide 64 GW# [003] 64 Ecallantide 64 targeted anticancer biopharmaceuticals 64 TRIOLEX HE# APOPTONE HE# 64 cathepsin K inhibitor 64 Activity Assay 64 Nipent R 64 TRANSDUR ® 64 proteasome inhibitor 64 HepeX B 64 Angiocept 64 APC Targeting Technology 64 PEG irinotecan 64 HuMax CD#b 64 RONDEL ™ 64 histamine dihydrochloride 64 acyclovir Lauriad ® 64 relapsed MM 64 Allovectin 7 64 biosurgical 64 Thalomid ® 64 Icatibant 64 visit www.genenews.com 64 Captisol ® 64 ZADAXIN ® 64 Forodesine HCl 64 Vertex hepatitis C 64 lucinactant 64 anticancer compound 64 Unigene nasal calcitonin 64 HuCNS SC ® 64 Small Modular SMIP 64 Augment TM 64 humanised monoclonal antibody 64 staphylococcal vaccine 64 Demonstrates Positive 64 Acetavance TM intravenous acetaminophen 64 evaluating picoplatin 64 pharmacologically active isomer 64 utilizes InSite Vision 64 MEK Inhibitor 64 R Saizen R 64 SNT MC# 64 HepeX B TM 64 nalbuphine ER 64 incyclinide 64 REGEN trial 64 pain palliation 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 Gel repository corticotropin injection 64 Submits IND 64 ChronVac C R 64 methylnaltrexone bromide 64 trastuzumab DM1 T DM1 64 oral probiotic 64 mitogen activated ERK kinase 64 intranasal delivery 64 Advanced Melanoma 64 TELINTRA R 64 Eraxis 64 Alzhemed TM 64 recombinant PSMA vaccine 64 Omacetaxine 64 pharmacogenomic translational research 64 Nanobody R 64 AdVac ® 64 Diabetic Foot Ulcer 64 MyVax R 64 Urocidin TM 64 NV1FGF 64 GRNOPC1 contains 64 Vaxfectin TM adjuvant 64 recombinant biopharmaceutical 64 hepatitis B immune globulin 64 Gefitinib 64 ularitide 64 TRAIL receptor antibodies 64 JAK Inhibitor 64 herpetic keratitis 64 NB S# strontium malonate 64 IV acetaminophen 64 Leukine ® 64 Sebivo 64 ® bortezomib 64 StemEx R 64 Tumour Vascular Disrupting Agent 64 AzaSite Xtra 64 proprietary BiTE ® 64 oral dihydropyrimidine dehydrogenase DPD 64 HuCAL antibodies 64 humanized monoclonal 64 immatics 64 Troxatyl 64 Pegloticase 64 Celacade TM technology 64 Cloretazine ® 64 investigational integrase inhibitor 64 XYOTAX TM 64 Intravenous Human 64 DXL# 64 chemotherapy induced neutropenia 64 Ostabolin C TM 64 Amrubicin 64 Zoraxel TM 64 Pralatrexate 64 BUPHENYL R 64 TG# [003] 64 novel antifolate currently 64 Bioaccelerate compounds under 64 telomerase therapeutic 64 arsenic trioxide injection 64 Generx ™ 64 recombinant FVIII 64 Ambrisentan 64 VivaGel ™ 64 DexaSite 64 platinum chemotherapeutic 64 Phase 2b Clinical Trial 64 sitaxsentan 64 Dyax phage display 64 PEGylated Fab fragment 64 TLK# 64 OvaRex ® MAb 64 UPLYSO 64 Nektar proprietary 64 Exherin TM 64 dutogliptin 64 Pfizer Camptosar 64 TPI ASM8 64 somatostatin analog 64 Kuvan sapropterin dihydrochloride 64 Albugon 64 Campath ® 64 SILENOR 64 cisplatin gemcitabine 64 Inhalation Solution 64 receptor tyrosine kinase inhibitor 64 platform HDL Mimetic 64 Doripenem 64 delta opioid receptor 64 PHX# 64 Demonstrates Significant 64 Intravitreal 64 Successfully Completes Phase 64 buccal insulin spray 64 Completes Enrollment 64 OncoVEX GM CSF 64 Juvaris BioTherapeutics 64 opioid induced bowel dysfunction 64 Antitumor Activity 64 Lixivaptan 64 Synavive ™ 64 Stapled Peptide 64 FUSILEV enhances 64 Urocidin 64 Transdermal Patch 64 HCV RNA polymerase 64 Zemplar 64 CEL SCI Phase III 64 orally disintegrating 64 hereditary emphysema 64 erlotinib Tarceva ® 64 Cinryze ™ 64 Spiegelmer ® 64 Irinotecan 64 Bioral Amphotericin B. 64 Mg Usa 64 phase IIb clinical 64 constipation OIC 64 Granted Orphan Drug 64 Cotara ® 64 systemic RNAi 64 PSMA ADC 64 Presents Positive 64 JAK inhibitors 64 NPC 1C 64 Zolpimist ™ 64 Tesetaxel 64 mGluR5 NAM 64 NEBIDO VANTAS SUPPRELIN LA 64 R#/MEM # 64 corticosteroid dexamethasone 64 DOS# 64 Alferon LDO 64 peripherally acting 64 Ferumoxytol 64 Androxal TM 64 Panzem 64 coronary stent merged 64 PF # [002] 64 induced macular edema 64 orally bioavailable mimics 64 Ketotransdel 64 CCR5 mAb 64 Genasense R oblimersen 64 iSONEP TM 64 Gemzar ® 64 Fast Track Status 64 JAK2 inhibitor 64 uricase 64 biologic antibody 64 novel immunotherapies 64 valtorcitabine 64 investigational therapies 64 RNAi therapeutic platform 64 topically administered 64 BCG refractory carcinoma 64 intravenous AAT 64 Bioral 64 Pathway Inhibitor 64 MediGene focuses 64 Onyx Pharmaceuticals Announces 64 Interferon alpha 64 Psoraxine R 64 Modrenal R 64 rusalatide acetate 64 Friedreich Ataxia FRDA 64 alpha interferons 64 LEVADEX ™ 64 small molecule Hedgehog 64 sodium glucose transporter 64 Elagolix 64 Quinamed 64 treat opioid induced 64 trastuzumab Herceptin R 64 Degarelix 64 SPRIX ® 64 pregabalin Lyrica 64 Present Preclinical Data 64 Phase #b/#a clinical 64 Trobalt 64 Fc fusion protein 64 BRIM2 64 tumor vascular disrupting 64 Onalta TM 64 Silodosin 64 Shows Statistically Significant 64 Perforomist TM formoterol fumarate 64 LEP ETU 64 Egrifta 64 zolpidem tartrate sublingual tablet 64 anti infective treatments 64 DepoVax TM 64 programs visit http:/www.bionovo.com 64 Aeolus Pharmaceuticals Announces 64 paclitaxel Taxol ® 64 biologic therapeutics 64 mesylate tablets approved 64 Pazopanib 63 EndoTAG TM 63 Frova ® 63 oral immunomodulatory 63 Enkephalin 63 ocular formulation 63 muscarinic receptor agonist 63 proven DuraSite ® 63 5 FU leucovorin 63 nasal calcitonin product 63 immunotherapeutic approaches 63 VIR# 63 topical dermatology 63 buccal spray 63 Liposomal 63 Desvenlafaxine 63 HyperAcute 63 gepirone ER 63 Azedra TM 63 faropenem 63 ZEFTERA TM Zevtera TM 63 SUPPRELIN R LA 63 allosteric modulator NAM 63 Anturol TM 63 regorafenib 63 NEUMUNE 63 Microplasmin 63 drug zotarolimus 63 Darinaparsin 63 Bicifadine 63 Lisofylline LSF 63 YONDELIS R 63 AKT inhibitor 63 orally inhaled migraine 63 EGS# 63 JAK2 Inhibitor 63 VitiGam 63 HEPLISAV TM hepatitis B 63 Prodarsan ® 63 FDA APPROVES 63 allogeneic HSCT 63 Genentech Rituxan 63 orally inhaled 63 CINTREDEKIN BESUDOTOX 63 luliconazole 63 Bacillus Calmette Guerin 63 IMiDs 63 INS# [001] 63 CYCLOSET ® 63 cobiprostone 63 Gliadel Wafer 63 metastatic neuroendocrine tumors 63 MTP inhibitor 63 Intercell vaccine 63 Bayer Onyx 63 MelaFind R 63 treat lupus renal 63 Poly ICLC 63 Trofex 63 tizanidine hydrochloride short 63 anticoagulant reversing agent 63 commercializes oncology 63 treat nephropathic cystinosis 63 Valdoxan 63 calcineurin inhibitor 63 Tarceva TM 63 platforms GVAX 63 TELINTRA 63 Qutenza TM 63 candidate Imagify TM 63 Antibody Drug Conjugate 63 alkylating agent 63 Alexza Staccato 63 GVAX R 63 etanercept Enbrel 63 Pivotal Phase III 63 investigational mTOR inhibitor 63 lapatinib Tykerb 63 iSONEP ™ 63 carbohydrate polymers 63 Telatinib 63 Cerashield ™ 63 investigational hepatitis B 63 omacetaxine mepesuccinate 63 Prosaptide 63 effector function 63 ALVESCO ® 63 Selzentry Celsentri 63 ZFP Therapeutics 63 syndrome overactive bladder 63 TH# [003] 63 treat GI GVHD 63 XL# XL# 63 Bendamustine 63 huC# DM4 63 Anticalin R 63 Novavax VLP vaccine 63 Patients Treated With 63 treat male hypogonadism 63 PRT# 63 3 registrational trial 63 vidofludimus 63 transmucosal delivery system 63 GTC recombinant human 63 essential thrombocythemia ET 63 Vascugel ® 63 Orencia abatacept 63 budesonide foam 63 HyACT 63 INTERCEPT red 63 Aztreonam 63 ASONEP TM 63 Vidaza R 63 SILENOR TM doxepin HCl 63 AzaSite TM 63 cysteamine bitartrate 63 systemic RNAi therapeutic 63 INTEGRILIN ® 63 MP4 molecule 63 ONCASPAR 63 PEG SN# 63 Solzira TM 63 alvespimycin 63 HuMax CD4 63 sulfonylurea glimepiride 63 selective androgen receptor modulator 63 TFChem licenses 63 Onalta ™ 63 Medidur ™ FA 63 CTAP# 63 Curaxin CBLC# 63 Fleximer R 63 XP #L 63 nephropathic cystinosis 63 MAb therapy 63 MT#/MEDI-# 63 Panzem NCD 63 topical antifungal 63 investigational antiplatelet agent 63 antibody MAb 63 Vernakalant 63 Naive Patients 63 Smac mimetic 63 equine osteoarthritis 63 investigational pan BCR 63 CRLX# 63 Dacetuzumab 63 REMINYL ® 63 deCODE AF TM 63 Zenpep 63 PLK1 SNALP 63 ATIR 63 TOCOSOL R 63 Ceflatonin R 63 HCV NS5B polymerase 63 Small Molecule 63 Provectus Pharmaceuticals specializes 63 Aridol TM 63 proprietary bioresorbable polymer 63 non alcoholic steatohepatitis 63 injectable formulations 63 AN# novel 63 Alocrest 63 Receives Positive Opinion 63 pipeline ImmunoGen collaborators 63 deforolimus 63 Synerx Pharma 63 toenail onychomycosis 63 systemically administered 63 CCX# 63 resorbable biomaterials 63 skeletal sarcomere activator 63 rifalazil 63 novel peptide 63 Pemetrexed 63 induced mucositis 63 Transdrug ® nanoparticle 63 Excellarate TM 63 isoform selective 63 RNAi therapeutic targeting 63 plasma kallikrein inhibitor 63 Ceragenin ™ 63 SANVAR 63 Tykerb lapatinib 63 Ophena 63 SIR Spheres 63 Neo Kidney Augment 63 TIMERx 63 Nanobody ® 63 Restanza TM 63 topical gel formulation 63 factor VIIa 63 Xifaxan rifaximin 63 miconazole Lauriad R 63 visit http:/www.mannkindcorp.com 63 Zoraxel 63 recombinant interferon 63 AMPK activators 63 antimitotic 63 NanoCrystal technology 63 PDE# inhibitors 63 Anthim 63 immuno therapeutic 63 DEB# 63 Inhalation Aerosol 63 epoetin alpha 63 depsipeptide 63 Octreotide 63 Epanova 63 Ketotransdel TM 63 DepoCyt 63 Prednisporin 63 Nexavar ® 63 topical non steroidal 63 generation purine nucleoside 63 Orally administered 63 Investigational Compound 63 Dual Opioid 63 Argatroban 63 lymphoid tumors 63 BRAF inhibitor 63 ocular inflammatory 63 Japanese Encephalitis Vaccine 63 oral salmon calcitonin 63 TKM PLK1 63 TNF alpha antagonist 63 antiangiogenic agent 63 Genz # 63 Cardium Therapeutics TM 63 BRAF inhibitors 63 GelSite polymer 63 DepoDur TM 63 TM Aganocide 63 invasive candidiasis 63 Mg Uk 63 liposome encapsulated 63 oxybutynin gel 63 HuMax EGFr 63 Hepatocellular Carcinoma HCC 63 neuronal nicotinic receptor NNR 63 AdhTAP 63 DiLA2